Ticker: OPRX

RBC Capital Markets has downgraded OptimizeRx Corp (NASDAQ: OPRX) to "sector perform," reflecting concerns over its DTC segment and lower revenue projections for 2025. The stock's price target is cut to $6 amid leadership instability and mixed performance in healthcare offerings.